The purpose of the WHO guideline for clinical management of exposure to lead is to assist physicians in making decisions about the diagnosis and treatment of lead exposure for individual patients and in mass poisoning incidents. The guidelines present evidence-informed recommendations on i) the interpretation of blood lead concentrations; ii) use of gastrointestinal decontamination; iii) use of a chelating agent; and iv) use of nutritional supplements.